Skip to content

Surpass Streamline M003SFD040400Recalls & reported problems

Stryker Corporation · Flow Diverter · Class 3 · Implant

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 07613252648802), received between Aug 13, 2019 and Aug 13, 2019 — classified as 1 injury.

The most frequently reported specific device problem is “Activation Failure” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Activation Failure1

Patient problems

  • Neurological Deficit/Dysfunction1
  • Stroke/CVA1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryAug 13, 2019Activation Failure; Activation Failure

    IT WAS REPORTED THAT THE PATIENT WAS TREATED WITH A STENT FLOW DIVERTER (SUBJECT DEVICE). THE SUBJECT STENT WAS IMPLANTED OVER THE OPTHALMIC ARTERY BUT IT DID NOT OPPOSE THE PARENT VESSEL WALL COMPLETELY. ANGIOPLASTY WAS PERFORMED DUE TO THE STENT MALPOSITION. 6 HOURS POST PROCEDURE, THE PATIENT DEVELOPED AN EYE STROKE AND THE PATIENT VISION IS NOW CLOUDY. ACCORDING TO THE PHYSICIAN, THE EYE STROKE AND PATIENT¿S CLOUDY VISION WERE CAUSED BY USING THE BALLOON TO ANGIOPLASTY TO STENT (SUBJECT DEVICE). NO FURTHER INFORMATION IS AVAILABLE.

    Patient problems: Neurological Deficit/Dysfunction; Stroke/CVA

    MAUDE report 8889390 ↗

Other Intracranial aneurysm flow diverter devices

All Intracranial aneurysm flow diverter devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page